Business

A personalized cancer vaccine could be available as soon as 2027. Here’s what we know

Fast Company·Oct 23, 2026 · 2:43 PM CT
Readthrough summary

A personalized mRNA vaccine for melanoma, built on the technology behind the Pfizer and Moderna COVID shots, can cut the risk of recurrence or death nearly in half. Fast Company says it could be available as soon as 2027.

Summary written by Readthrough from the original article. The full story, with photos and any updates, is at Fast Company.

More Business

The White House·

Fact Sheet: President Donald J. Trump Further Modifies Canadian Products Subject to Tariffs Under Section 338

President Trump signed a proclamation narrowing the Section 338 tariffs on some Canadian products, the White House said, removing items such as plywood sheets, some paper products and certain machinery. The tariffs were imposed after Canada walked away from a near-final trade deal and put retaliatory tariffs on about $20 billion of U.S. exports.

Fox Business·

Trump announces $275M nursing-home nurse initiative at Florida midterm rally

At a Fort Myers, Florida, rally, Trump announced a $275 million initiative to recruit and retain nursing-home nurses. HHS will offer nurses up to $50,000 for three years of nursing-home service.

HM Treasury·

Jackdaw gas field gets green light

The UK Energy Secretary cleared the way for gas production at the Jackdaw field, which could start supplying homes by the end of this month and lift domestic gas output by about 6% at peak. The Chancellor also announced a new Energy Wealth Fund with a £2 billion downpayment.

CNBC·

In hunt for Starlink alternative, Ukraine partners with Nokia and satellite maker ICEYE

After SpaceX restricted Starlink and Starshield service in Ukraine, Kyiv signed a letter of intent with Finland's Nokia and satellite maker ICEYE to develop defense and satellite communications. An investor told CNBC a true alternative could be two to three years away.